Joint modelling of mental health markers through pregnancy: a Bayesian semi-parametric approach

J Appl Stat. 2023 Jan 13;51(2):388-405. doi: 10.1080/02664763.2022.2154329. eCollection 2024.

Abstract

Maternal depression and anxiety through pregnancy have lasting societal impacts. It is thus crucial to understand the trajectories of its progression from preconception to postnatal period, and the risk factors associated with it. Within the Bayesian framework, we propose to jointly model seven outcomes, of which two are physiological and five non-physiological indicators of maternal depression and anxiety over time. We model the former two by a Gaussian process and the latter by an autoregressive model, while imposing a multidimensional Dirichlet process prior on the subject-specific random effects to account for subject heterogeneity and induce clustering. The model allows for the inclusion of covariates through a regression term. Our findings reveal four distinct clusters of trajectories of the seven health outcomes, characterising women's mental health progression from before to after pregnancy. Importantly, our results caution against the loose use of hair corticosteroids as a biomarker, or even a causal factor, for pregnancy mental health progression. Additionally, the regression analysis reveals a range of preconception determinants and risk factors for depressive and anxiety symptoms during pregnancy.

Keywords: Bayesian non-parametrics; Dirichlet process; Gaussian process; mental health; pregnancy; trajectory clustering.

Grants and funding

This work was supported by the Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2019-T2-2-100], the Singapore Ministry of Health's National Medical Research Council under its Open Fund – Young Individual Research Grant [OFYIRG19nov-0010] and the Singapore National Research Foundation under its Translational and Clinical Research Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council [NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/2014]. Additional funding is provided by the Singapore Institute for Clinical Sciences, Agency for Science Technology and Research.